Literature DB >> 18283607

Signaling mechanisms of GPCR ligands.

Philip G Strange1.   

Abstract

G protein-coupled receptors constitute one of the major classes of drug targets, so understanding the mechanisms of signaling through these receptors is of great importance. This review covers some of the recent advances in G protein-coupled receptor signaling. A high resolution structure of the beta 2-adrenergic receptor has been reported, as well as several molecular switches involved in receptor activation. It has also been realised that receptors and G proteins and their subunits may not always separate upon receptor activation. The definition of the ability of these receptors to signal has been expanded considerably with the realisation that some signaling may occur independently of G proteins, that some signaling events may differ in their pharmacological profiles and that formation of heterodimers of these receptors may provide new avenues for both signaling and drug design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283607

Source DB:  PubMed          Journal:  Curr Opin Drug Discov Devel        ISSN: 1367-6733


  18 in total

1.  Biased signaling at chemokine receptors.

Authors:  Jenny Corbisier; Céline Galès; Alexandre Huszagh; Marc Parmentier; Jean-Yves Springael
Journal:  J Biol Chem       Date:  2015-01-22       Impact factor: 5.157

2.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

3.  Study of a structurally similar kappa opioid receptor agonist and antagonist pair by molecular dynamics simulations.

Authors:  Michal Kolinski; Slawomir Filipek
Journal:  J Mol Model       Date:  2010-02-27       Impact factor: 1.810

4.  Catecholamine-independent heart rate increases require Ca2+/calmodulin-dependent protein kinase II.

Authors:  Zhan Gao; Madhu V Singh; Duane D Hall; Olha M Koval; Elizabeth D Luczak; Mei-ling A Joiner; Biyi Chen; Yuejin Wu; Ashok K Chaudhary; James B Martins; Thomas J Hund; Peter J Mohler; Long-Sheng Song; Mark E Anderson
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-15

5.  Thyrotropin receptor stimulates internalization-independent persistent phosphoinositide signaling.

Authors:  Alisa Boutin; Michael D Allen; Elizabeth Geras-Raaka; Wenwei Huang; Susanne Neumann; Marvin C Gershengorn
Journal:  Mol Pharmacol       Date:  2011-04-27       Impact factor: 4.436

6.  Structural Basis of the Activation of Heterotrimeric Gs-Protein by Isoproterenol-Bound β1-Adrenergic Receptor.

Authors:  Minfei Su; Lan Zhu; Yixiao Zhang; Navid Paknejad; Raja Dey; Jianyun Huang; Ming-Yue Lee; Dewight Williams; Kelsey D Jordan; Edward T Eng; Oliver P Ernst; Joel R Meyerson; Richard K Hite; Thomas Walz; Wei Liu; Xin-Yun Huang
Journal:  Mol Cell       Date:  2020-08-19       Impact factor: 17.970

Review 7.  Regulation, Signaling, and Physiological Functions of G-Proteins.

Authors:  Viktoriya Syrovatkina; Kamela O Alegre; Raja Dey; Xin-Yun Huang
Journal:  J Mol Biol       Date:  2016-08-08       Impact factor: 5.469

8.  AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling.

Authors:  Rajaganapathi Jagannathan; Suma Kaveti; Russell W Desnoyer; Belinda Willard; Michael Kinter; Sadashiva S Karnik
Journal:  PLoS One       Date:  2010-09-03       Impact factor: 3.240

9.  Interferonβ-1b Induces the Expression of RGS1 a Negative Regulator of G-Protein Signaling.

Authors:  Tiffany Tran; Pedro Paz; Sharlene Velichko; Jill Cifrese; Praveen Belur; Ken D Yamaguchi; Karin Ku; Parham Mirshahpanah; Anthony T Reder; Ed Croze
Journal:  Int J Cell Biol       Date:  2011-01-17

10.  Investigation of D₂ receptor-agonist interactions using a combination of pharmacophore and receptor homology modeling.

Authors:  Marcus Malo; Lars Brive; Kristina Luthman; Peder Svensson
Journal:  ChemMedChem       Date:  2012-02-07       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.